3T Biosciences - TCR Target ID And Therapeutic Discovery

Details:

Details about 3T Biosciences - TCR Target ID And Therapeutic Discovery

We are solving a major bottleneck in the field of targeted biotherapeutics in oncology – the identification of novel targets for the treatment of solid tumors.

Employees:

Employees at 3T Biosciences - TCR Target ID And Therapeutic Discovery

John Leonard

Associate Director at 3T Biosciences - TCR Target ID And Therapeutic Discovery

Luke Lee

Chief Executive Officer, Co-Founder at 3T Biosciences - TCR Target ID And Therapeutic Discovery

Corinn Whann

Senior Executive Assistant to Chief Executive Officer at 3T Biosciences - TCR Target ID And Therapeutic Discovery

Leah Sibener

Co-founder, VP of Therapeutic Discovery at 3T Biosciences - TCR Target ID And Therapeutic Discovery

Glenn Dourado

3T Biosciences - TCR Target ID And Therapeutic Discovery

Stefan Scherer

Chief Executive Officer at 3T Biosciences - TCR Target ID And Therapeutic Discovery

Lena Flood

Scientist II at 3T Biosciences - TCR Target ID And Therapeutic Discovery

Hans-Peter Gerber

CSO and Cofounder at 3T Biosciences - TCR Target ID And Therapeutic Discovery

Leah Sibener

Co-Founder, Head of Therapeutic Discovery at 3T Biosciences - TCR Target ID And Therapeutic Discovery

Marvin Gee

VP, Target Discovery, Co-Founder at 3T Biosciences - TCR Target ID And Therapeutic Discovery

Aurelien Sarde

Scientist at 3T Biosciences - TCR Target ID And Therapeutic Discovery

Bindu Hegde

Senior Scientist at 3T Biosciences - TCR Target ID And Therapeutic Discovery